Benchmark Capital backs Alternis with $4.5m, Congruency raises further $10.25m, 3i & ACT invest in Intense Photonics
Credit Lyonnais Asset Management Private Equity and BNP Paribas join Carlyle in a rare dot-com play.
Two new hires will develop the Portfolio development team’s early growth strategy
Infopress printing money; Spectrum Equity storing value; First Hop, second round; YourNews closes second round
Back To Basics 2001-07-17 Staff Writer As the French say, plus ça change, plus ç’est la meme chose ('the more things change, the more they stay the same'). In 1988, when I wrote my first treatise on venture capital, I mentioned a phenomenon which had been apparent to me and other experienced players in this
IRegent, Jim Mellon’s Hong Kong investment group, provides initial backing for a new genetic medicine fund.
John Major will be the firm's European chairman. Christopher Finn explains why, and looks at other developments inside the firm.
Epartners has given back its e-money. The firm has decided it cannot invest $520m of the $650m fund it raised for internet companies last July and will return it to investors including Morgan Stanley and Softbank.
The venture capitalist has announced a $950m fund aimed at biotech and IT, but not the internet. Institutionals on both sides of the Atlantic contributed to the fund.
Money from Merlin Bioscience, Citigroup, Verus and 3i; initial close from Vertex.